| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19658399
[patent_doc_number] => 20240425464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => Substituted Monohydrazides as Potent Antifungal Agents
[patent_app_type] => utility
[patent_app_number] => 18/743737
[patent_app_country] => US
[patent_app_date] => 2024-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18743737
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/743737 | Substituted Monohydrazides as Potent Antifungal Agents | Jun 13, 2024 | Pending |
Array
(
[id] => 19554754
[patent_doc_number] => 20240366546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => ANTI-HELICOBACTER PYLORI DERIVATIVE CONTAINING DIHYDROSTILBENE PARENT NUCLEUS AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/738087
[patent_app_country] => US
[patent_app_date] => 2024-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738087
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/738087 | ANTI-HELICOBACTER PYLORI DERIVATIVE CONTAINING DIHYDROSTILBENE PARENT NUCLEUS AND PREPARATION METHOD AND APPLICATION THEREOF | Jun 9, 2024 | Pending |
Array
(
[id] => 19922933
[patent_doc_number] => 12297204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents
[patent_app_type] => utility
[patent_app_number] => 18/736710
[patent_app_country] => US
[patent_app_date] => 2024-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2134
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18736710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/736710 | 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents | Jun 6, 2024 | Issued |
Array
(
[id] => 19745581
[patent_doc_number] => 20250034146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => ELECTRO-PHOTOCHEMICAL SYNTHESIS OF 1,2,4-TRIAZOLO-[4,3-A]PYRAZINE
[patent_app_type] => utility
[patent_app_number] => 18/661871
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 352
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18661871
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/661871 | ELECTRO-PHOTOCHEMICAL SYNTHESIS OF 1,2,4-TRIAZOLO-[4,3-A]PYRAZINE | May 12, 2024 | Pending |
Array
(
[id] => 20121575
[patent_doc_number] => 20250236606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => POLYDENTATE ORGANIC LIGAND, METALLO-SUPRAMOLECULAR POLYMER, POLYMER FILM AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/661628
[patent_app_country] => US
[patent_app_date] => 2024-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18661628
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/661628 | Polydentate organic ligand, metallo-supramolecular polymer, polymer film and preparation method thereof | May 11, 2024 | Issued |
Array
(
[id] => 19448869
[patent_doc_number] => 20240308999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT
[patent_app_type] => utility
[patent_app_number] => 18/653750
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653750
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653750 | INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT | May 1, 2024 | Pending |
Array
(
[id] => 19432395
[patent_doc_number] => 20240300893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => SMALL MOLECULE COMPOUNDS TARGETING SRSF6 PROTEIN AND THEIR PREPARATION METHODS AND APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/652809
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652809 | SMALL MOLECULE COMPOUNDS TARGETING SRSF6 PROTEIN AND THEIR PREPARATION METHODS AND APPLICATIONS | Apr 30, 2024 | Pending |
Array
(
[id] => 19541698
[patent_doc_number] => 20240358734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => DISCOVERY OF NOVEL TRPV1 CHANNEL BLOCKERS BY HIGH-THROUGHPUT SCREENING OF MARINE NATURAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/647744
[patent_app_country] => US
[patent_app_date] => 2024-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18647744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/647744 | DISCOVERY OF NOVEL TRPV1 CHANNEL BLOCKERS BY HIGH-THROUGHPUT SCREENING OF MARINE NATURAL PRODUCTS | Apr 25, 2024 | Pending |
Array
(
[id] => 19418380
[patent_doc_number] => 20240294503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/639608
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639608
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639608 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | Apr 17, 2024 | Pending |
Array
(
[id] => 19339276
[patent_doc_number] => 12049454
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-07-30
[patent_title] => 5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/623808
[patent_app_country] => US
[patent_app_date] => 2024-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4504
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18623808
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/623808 | 5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | Mar 31, 2024 | Issued |
Array
(
[id] => 19667446
[patent_doc_number] => 12180173
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-31
[patent_title] => 5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/623544
[patent_app_country] => US
[patent_app_date] => 2024-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18623544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/623544 | 5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound | Mar 31, 2024 | Issued |
Array
(
[id] => 19763177
[patent_doc_number] => 12221450
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-02-11
[patent_title] => 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents
[patent_app_type] => utility
[patent_app_number] => 18/618824
[patent_app_country] => US
[patent_app_date] => 2024-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5853
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18618824
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/618824 | 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents | Mar 26, 2024 | Issued |
Array
(
[id] => 20007364
[patent_doc_number] => 20250145586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => KINASE INHIBITORS FOR THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/601218
[patent_app_country] => US
[patent_app_date] => 2024-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18601218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/601218 | KINASE INHIBITORS FOR THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS | Mar 10, 2024 | Pending |
Array
(
[id] => 19360776
[patent_doc_number] => 20240262810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host Disease
[patent_app_type] => utility
[patent_app_number] => 18/595801
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18595801
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/595801 | Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host Disease | Mar 4, 2024 | Pending |
Array
(
[id] => 20729127
[patent_doc_number] => 12636371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Chemically coupled transporter for low-hydrophobicity bioactive drugs into the central nervous system
[patent_app_type] => utility
[patent_app_number] => 18/590749
[patent_app_country] => US
[patent_app_date] => 2024-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9650
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18590749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/590749 | Chemically coupled transporter for low-hydrophobicity bioactive drugs into the central nervous system | Feb 27, 2024 | Issued |
Array
(
[id] => 19288306
[patent_doc_number] => 20240224789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => IONIC COMPOUND AND APPLICATION THEREOF, PEROVSKITE PRECURSOR SOLUTION, PEROVSKITE MATERIAL, SOLAR CELL, AND ELECTRIC APPARATUS
[patent_app_type] => utility
[patent_app_number] => 18/587979
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18587979
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/587979 | IONIC COMPOUND AND APPLICATION THEREOF, PEROVSKITE PRECURSOR SOLUTION, PEROVSKITE MATERIAL, SOLAR CELL, AND ELECTRIC APPARATUS | Feb 26, 2024 | Pending |
Array
(
[id] => 19299934
[patent_doc_number] => 20240228503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => TRIAZOLE-SUBSTITUTED IMIDAZO[1,2-A]PYRIMIDINES AS CGAS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/586620
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18586620
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/586620 | Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors | Feb 25, 2024 | Issued |
Array
(
[id] => 19571775
[patent_doc_number] => 20240376067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => PROCESS OF MAKING SOMATOSTATIN MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/587187
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18587187
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/587187 | PROCESS OF MAKING SOMATOSTATIN MODULATORS | Feb 25, 2024 | Pending |
Array
(
[id] => 19464073
[patent_doc_number] => 20240317742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => METHODS OF PREPARING INTERMEDIATES OF HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/584163
[patent_app_country] => US
[patent_app_date] => 2024-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18584163
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/584163 | METHODS OF PREPARING INTERMEDIATES OF HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | Feb 21, 2024 | Pending |
Array
(
[id] => 19769894
[patent_doc_number] => 20250051320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => CRBN LIGANDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/583347
[patent_app_country] => US
[patent_app_date] => 2024-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18583347
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/583347 | CRBN LIGANDS AND USES THEREOF | Feb 20, 2024 | Pending |